Response to: ‘COVID-19 in patients with rheumatological diseases treated with Anti-TNF’ by Brito et al and ‘Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China ‘hot spot’ versus in US ‘hot spot’: similarities and differences’ by Zhao et al

Kristin M D’Silva; Naomi Serling-Boyd; Rachel Wallwork; Tiffany Hsu; Jeffrey A Sparks; Zachary Scott Wallace

首页> 外文期刊>Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research >Response to: ‘COVID-19 in patients with rheumatological diseases treated with Anti-TNF’ by Brito et al and ‘Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China ‘hot spot’ versus in US ‘hot spot’: similarities and differences’ by Zhao et al

【24h】

Response to: ‘COVID-19 in patients with rheumatological diseases treated with Anti-TNF’ by Brito et al and ‘Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China ‘hot spot’ versus in US ‘hot spot’: similarities and differences’ by Zhao et al

机译：回应：Brito等人的“抗TNF”和抗TNF'治疗的流动理疾病患者Covid-19，并在美国热点的中国热点患者的临床特征和患者患者的临床特征和结果。：Zhao等人的相似之处和差异

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research》 |2021年第5期|共1页
作者
Kristin M D’Silva; Naomi Serling-Boyd; Rachel Wallwork; Tiffany Hsu; Jeffrey A Sparks; Zachary Scott Wallace;
展开▼
作者单位

Division of Rheumatology Allergy and Immunology;

Division of Rheumatology Allergy and Immunology;

Division of Rheumatology Allergy and Immunology;

Division of Rheumatology Inflammation and Immunity;

Division of Rheumatology Inflammation and Immunity;

Division of Rheumatology Allergy and Immunology;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词
autoimmunity; biological therapy; epidemiology;

机译：自身免疫;生物疗法;流行病学;

相似文献

外文文献
中文文献
专利

1. Clinical characteristics of hospitalised patients with schizophrenia who were suspected to have coronavirus disease(COVID-19)in Hubei Province,China [J] . Xuebing Liu, Hong Lin, Haifeng Jiang, 综合精神医学（英文） . 2020,第002期
2. Characteristics and Outcomes of Coronavirus Disease 2019 (COVID-19) Infection among Children Admitted in Al-Imam Abdulrahman Al Faisal Hospital in Riyadh, Saudi Arabia [J] . Abdullah H. Alhamoud, Hareth A. Aldosaimani, Abdullah A. Alyahya, 儿科学期刊（英文） . 2021,第002期
3. HOT SPOTS OF HEPATITIS B VIRUS FOR GENETIC MUTATION IN CHINESE PATIENTS AND ITS CLINICAL SIGNIFICANCE [J] . 骆抗先, 侯金林中华医学杂志：英文版 . 1996,第002期
4. Clinical characteristics of 1327 patients with coronavirus disease 2019(COVID-19)in the largest Fangcang shelter hospital in Wuhan [J] . Chong Lu, Chao Yang, Hui Sun, 中华医学杂志（英文版） . 2021,第002期
5. Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China ‘hot spot’ versus in US ‘hot spot’: similarities and differences [J] . Jun Zhao, Rongrong Pang, Jian Wu, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2021,第5期

机译：中国热点患者患者患者的临床特征及成果，在美国热点的热点 - 中的“热点”：相似之处和差异
6. Comorbidities and rheumatological diseases at the time of COVID-19. Response to: ‘Rheumatic diseases in intensive care unit patients with COVID-19’ by Moiseev et al [J] . Sara Monti, Carlomaurizio Montecucco Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2021,第2期

机译：Covid-19时的羟基和风湿病疾病。回应：Moiseev等人的“重症监护室内患者的风湿性疾病”
7. Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: ‘Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?’ by Xie et al [J] . Carmen Magdalena Gamboa-Alonso, Gabriel Figueroa-Parra, Dionicio Angel Galarza-Delgado Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2021,第1期

机译：仍然早期为有风湿病患者的Covid-19抗疟疾药物的明确作用。回应：'羟基氯喹减少了风湿病患者Covid-19的风险：神话或现实？'通过谢等人
8. THAUDOMIDE TREATMENT IN 80 PATIENTS WITH AL AMYLOIDOSIS: TOLERABIL1TY, CLONAL DISEASE RESPONSE AND CLINICAL OUTCOME [C] . HJ-B. Goodman, H.J. Lachmann, R. Gallimore, International Symposium on Amyloidosis . 2005

机译：80例Al淀粉样症患者中的欺诈致瘤治疗：甲苯，克隆疾病反应和临床结果
9. Socioeconomic Status, Benzathine Penicillin Prophylaxis, and Clinical Outcomes in Patients with Rheumatic Heart Disease [D] . ?Yilgwan, Christopher Sabo 2020

机译：社会经济地位，苯甲丝青霉素预防，以及风湿性心脏病患者的临床结果
10. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US ‘hot spot’ [O] . Kristin M D’Silva, Naomi Serling-Boyd, Rachel Wallwork, -1

机译：冠状病毒疾病患者2019（Covid-19）和风湿病患者的临床特征及结果：美国热点的比较队列研究
11. Response to: ‘COVID-19 in patients with rheumatological diseases treated with Anti-TNF’ by Brito et al and ‘Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China ‘hot spot’ versus in US ‘hot spot’: similarities and differences’ by Zhao et al [O] . Kristin M D’Silva, Naomi Serling-Boyd, Rachel Wallwork, 2020

机译：反应：'Covid-19对抗TNF'治疗的风湿病患者，Brito等，并在中国热点的Covid-19和风湿病患者患者的临床特征和结果' ：Zhao等人的相似之处和差异

Response to: ‘COVID-19 in patients with rheumatological diseases treated with Anti-TNF’ by Brito et al and ‘Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China ‘hot spot’ versus in US ‘hot spot’: similarities and differences’ by Zhao et al

著录项

相似文献

相关主题

期刊订阅